Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) EBIT: 2009-2024

Historic EBIT for Geron (GERN) over the last 16 years, with Dec 2024 value amounting to -$173.7 million.

  • Geron's EBIT rose 50.78% to -$13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$63.1 million, marking a year-over-year increase of 69.66%. This contributed to the annual value of -$173.7 million for FY2024, which is 10.42% up from last year.
  • As of FY2024, Geron's EBIT stood at -$173.7 million, which was up 10.42% from -$193.9 million recorded in FY2023.
  • Geron's 5-year EBIT high stood at -$76.9 million for FY2020, and its period low was -$193.9 million during FY2023.
  • Over the past 3 years, Geron's median EBIT value was -$173.7 million (recorded in 2024), while the average stood at -$168.7 million.
  • In the last 5 years, Geron's EBIT crashed by 48.22% in 2021 and then grew by 10.42% in 2024.
  • Over the past 5 years, Geron's EBIT (Yearly) stood at -$76.9 million in 2020, then plummeted by 48.22% to -$114.0 million in 2021, then decreased by 21.54% to -$138.6 million in 2022, then crashed by 39.98% to -$193.9 million in 2023, then increased by 10.42% to -$173.7 million in 2024.